Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
International Journal of Oncology
Join Editorial Board Propose a Special Issue
Print ISSN: 1019-6439 Online ISSN: 1791-2423
Journal Cover
December-2026 Volume 69 Issue 6

Full Size Image

Cover Legend PDF

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
December-2026 Volume 69 Issue 6

Full Size Image

Cover Legend PDF

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Review Open Access

Metabolic‑epigenetic coupling via lysine lactylation drives cancer stemness and multidrug resistance (Review)

  • Authors:
    • Ying Yang
    • Nan Zhang
    • Dan Wang
    • Dongmei Ye
    • Yun Zhang
    • Xiaoju Li
  • View Affiliations / Copyright

    Affiliations: Department of Pathology, Honghui Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi 710054, P.R. China, Department of Pathology, The First Hospital of Nanchang City, Nanchang, Jiangxi 330000, P.R. China
    Copyright: © Yang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 142
    |
    Published online on: November 9, 2026
       https://doi.org/10.3892/ijo.2026.5955
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:


Abstract

Lysine lactylation couples glycolytic flux with epigenetic regulation, driving cancer stemness and therapeutic resistance. The Warburg effect generates L‑lactate, which through enzymatic (AARS1/2, HBO1, KAT8) and non‑enzymatic mechanisms deposits lactyl groups on histones and non‑histone proteins. This modification sustains cancer stem cell self‑renewal via histone mark deposition at stemness gene promoters and non‑histone modification of key regulators (SOX9 and β‑catenin). Concurrently, lactylation enhances DNA repair, suppresses ferroptosis and stabilizes stemness‑associated transcription factors, conferring resistance to chemotherapy, targeted agents and immunotherapy. Crosstalk with acetylation, ubiquitination and phosphorylation adds regulatory complexity. Preclinical targeting of lactate metabolism, lactyltransferases, or delactylases shows therapeutic promise, while lactylation‑based signatures may stratify patient responses. The present review synthesized current evidence establishing lactylation as a metabolic‑epigenetic node and summarized convergent resistance mechanisms that may inform future therapeutic strategies.
View Figures

Figure 1

Regulatory machinery of protein
lactylation. L-lactate is converted to lactyl-CoA or directly used
by writers (AARS1/2, HBO1, KAT8, KAT2A, GTPSCS) to deposit lactyl
groups on histones and non-histone proteins. Erasers (HDAC1-3,
SIRT3, SIRT6) remove lactylation. Readers (TRIM33, DPF2, BRD9)
interpret Kla marks. The process occurs in nucleus, cytoplasm and
mitochondria, with crosstalk to other PTMs. AARS1/2, alanyl-tRNA
synthetase 1/2; HBO1, histone acetyltransferase binding to ORC1;
KAT8, lysine acetyltransferase 8; KAT2A, lysine acetyltransferase
2A; GTPSCS, GTP-specific succinyl-CoA synthetase; HDAC1-3, histone
deacetylases 1-3; SIRT3, sirtuin 3; SIRT6, sirtuin 6; TRIM33,
tripartite motif-containing protein 33; DPF2, double PHD fingers 2;
BRD9, bromodomain-containing protein 9; Kla, lysine lactylation;
PTM, post-translational modification.

Figure 2

Metabolic reprogramming drives the
cancer lactylation landscape. There are four interconnected
mechanisms: Warburg effect and lactate accumulation; aerobic
glycolysis produces L-lactate, the substrate for lactylation,
oncogenic and hypoxic regulation; HIF1α, KRAS, BRAF and hypoxia
enhance glycolysis/lactate production, promoting
histone/non-histone lactylation; TME metabolic crosstalk; CAFs
provide lactate; lactate induces MOESIN, METTL3 and PD-L1
lactylation in immune cells, fostering immunosuppression; spatial
and single-cell heterogeneity; lactylation is enriched in CSCs and
varies across tumor regions, correlating with therapy resistance.
HIF1α, hypoxia-inducible factor 1α; KRAS, Kirsten rat
sarcoma viral oncogene homolog; BRAF, B-Raf proto-oncogene;
TME, tumor microenvironment; CAF, cancer-associated fibroblast;
MOESIN, membrane-organizing extension spike protein; METTL3,
methyltransferase-like 3; PD-L1, programmed death-ligand 1; CSC,
cancer stem cell; LDHA, lactate dehydrogenase A.

Figure 3

Metabolic-epigenetic remodeling by
lactylation drives therapy resistance through four core mechanistic
taxonomies. Lactate derived from glycolysis or the tumor
microenvironment fuels Kla on histones and non-histone proteins.
The four color-coded mechanistic branches represent the core
taxonomies of lactylation-mediated resistance: Enhanced DNA-damage
repair, including homologous recombination enhancement and DNA
repair pathway activation; Ferroptosis evasion, including
glutathione biosynthesis upregulation and lipid peroxidation
neutralization; Oncogenic stem-cell transcriptional programming,
including stemness transcription factor lactylation and
pluripotency gene activation; and immunosuppressive
microenvironment remodeling, including PD-L1 stabilization,
immunosuppressive myeloid cell polarization and CD8+ T cell
dysfunction. These mechanistic branches converge to confer
resistance across chemotherapy, targeted therapy and immunotherapy,
ultimately driving CSC-originated multidrug resistance and tumor
relapse Kla, lysine lactylation; CSC, cancer stem cell.
View References

1 

Duval AJ, Seker-Polat F, Rogozinska M, Kinali M, Walts AE, Neyisci O, Zhang Y, Li Z, Tanner EJ III, Grubbs AE, et al: SOX9 drives a stem-like transcriptional state and platinum resistance in high-grade serous ovarian cancer. J Clin Invest. 135:e1864672025. View Article : Google Scholar : PubMed/NCBI

2 

Hubert CG, Stauffer SR and Lathia JD: A TOX-ic axis of epigenetic stem cell maintenance and chemoresistance in colon cancer. PLoS Biol. 21:e30022952023. View Article : Google Scholar : PubMed/NCBI

3 

Li F, Si W, Xia L, Yin D, Wei T, Tao M, Cui X, Yang J, Hong T and Wei R: Positive feedback regulation between glycolysis and histone lactylation drives oncogenesis in pancreatic ductal adenocarcinoma. Mol Cancer. 23:902024. View Article : Google Scholar : PubMed/NCBI

4 

Yang J and Yu X, Xiao M, Xu H, Tan Z, Lei Y, Guo Y, Wang W, Xu J, Shi S and Yu X: Histone lactylation-driven feedback loop modulates cholesterol-linked immunosuppression in pancreatic cancer. Gut. 74:1859–1872. 2025. View Article : Google Scholar : PubMed/NCBI

5 

Yang Z, Yan C, Ma J, Peng P, Ren X, Cai S, Shen X, Wu Y, Zhang S, Wang X, et al: Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma. Nat Metab. 5:61–79. 2023. View Article : Google Scholar : PubMed/NCBI

6 

Liu R, Ren X, Park YE, Feng H, Sheng X, Song X, AminiTabrizi R, Shah H, Li L, Zhang Y, et al: Nuclear GTPSCS functions as a lactyl-CoA synthetase to promote histone lactylation and gliomagenesis. Cell Metab. 37:377–394.e9. 2025. View Article : Google Scholar

7 

Sun P, Ma L and Lu Z: Lactylation: Linking the Warburg effect to DNA damage repair. Cell Metab. 36:1637–1639. 2024. View Article : Google Scholar : PubMed/NCBI

8 

Feng F, Wu J, Chi Q, Wang S, Liu W, Yang L, Song G, Pan L, Xu K and Wang C: Lactylome analysis unveils lactylation-dependent mechanisms of stemness remodeling in the liver cancer stem cells. Adv Sci (Weinh). 11:e24059752024. View Article : Google Scholar : PubMed/NCBI

9 

Lv M, Yang X, Xu C, Song Q, Zhao H, Sun T, Liu J, Zhang Y, Sun G, Xue Y and Zhang Z: SIRT4 promotes pancreatic cancer stemness by enhancing histone lactylation and epigenetic reprogramming stimulated by calcium signaling. Adv Sci (Weinh). 12:e24125532025. View Article : Google Scholar : PubMed/NCBI

10 

Gan L, Sui Q, Xu MD, Yang F, Li M, Yuan Y, Lin Y, Zhang X, Bi G, Jiang W, et al: A tumor-derived lactate/ENO1 lactylation feedback loop facilitates osimertinib resistance of lung adenocarcinoma. Drug Resist Updat. 85:1013462026. View Article : Google Scholar : PubMed/NCBI

11 

Zhao X, Li M, Fu Y, Chen C, Chen Y, Xu L, Bao L, Ma Z, Xu J, Zhou S, et al: PSMD14-mediated PFKFB2 deubiquitination activates H3K27 lactylation to drive cancer stemness in gastric adenocarcinoma. Cell Death Differ. 33:813–830. 2026. View Article : Google Scholar

12 

Zhang D, Tang Z, Huang H, Zhou G, Cui C, Weng Y, Liu W, Kim S, Lee S, Perez-Neut M, et al: Metabolic regulation of gene expression by histone lactylation. Nature. 574:575–580. 2019. View Article : Google Scholar : PubMed/NCBI

13 

Liberti MV and Locasale JW: Histone lactylation: A new role for glucose metabolism. Trends Biochem Sci. 45:179–182. 2020. View Article : Google Scholar : PubMed/NCBI

14 

Zhang D, Gao J, Zhu Z, Mao Q, Xu Z, Singh PK, Rimayi CC, Moreno-Yruela C, Xu S, Li G, et al: Lysine L-lactylation is the dominant lactylation isomer induced by glycolysis. Nat Chem Biol. 21:91–99. 2025. View Article : Google Scholar

15 

Moreno-Yruela C, Bæk M, Monda F and Olsen CA: Chiral post-translational modification to lysine ε-Amino Groups. Acc Chem Res. 55:1456–1466. 2022. View Article : Google Scholar : PubMed/NCBI

16 

Zong Z, Xie F, Wang S, Wu X, Zhang Z, Yang B and Zhou F: Alanyl-tRNA synthetase, AARS1, is a lactate sensor and lactyltransferase that lactylates p53 and contributes to tumorigenesis. Cell. 187:2375–2392.e33. 2024. View Article : Google Scholar : PubMed/NCBI

17 

Ju J, Zhang H, Lin M, Yan Z, An L, Cao Z, Geng D, Yue J, Tang Y, Tian L, et al: The alanyl-tRNA synthetase AARS1 moonlights as a lactyltransferase to promote YAP signaling in gastric cancer. J Clin Invest. 134:e1745872024. View Article : Google Scholar : PubMed/NCBI

18 

Li H, Liu C, Li R, Zhou L, Ran Y, Yang Q, Huang H, Lu H, Song H, Yang B, et al: AARS1 and AARS2 sense L-lactate to regulate cGAS as global lysine lactyltransferases. Nature. 634:1229–1237. 2024. View Article : Google Scholar : PubMed/NCBI

19 

Niu Z, Chen C, Wang S, Lu C, Wu Z, Wang A, Mo J, Zhang J, Han Y, Yuan Y, et al: HBO1 catalyzes lysine lactylation and mediates histone H3K9la to regulate gene transcription. Nat Commun. 15:35612024. View Article : Google Scholar : PubMed/NCBI

20 

Xie B, Zhang M, Li J, Cui J, Zhang P, Liu F, Wu Y, Deng W, Ma J, Li X, et al: KAT8-catalyzed lactylation promotes eEF1A2-mediated protein synthesis and colorectal carcinogenesis. Proc Natl Acad Sci USA. 121:e23141281212024. View Article : Google Scholar : PubMed/NCBI

21 

Zhu R, Ye X, Lu X, Xiao L, Yuan M, Zhao H, Guo D, Meng Y, Han H, Luo S, et al: ACSS2 acts as a lactyl-CoA synthetase and couples KAT2A to function as a lactyltransferase for histone lactylation and tumor immune evasion. Cell Metab. 37:361–376.e7. 2025. View Article : Google Scholar

22 

Zhang C, Zhou T, Li C, Wang D, Tao J, Zhu X, Lu J, Ni J and Yao YF: Deciphering novel enzymatic and non-enzymatic lysine lactylation in Salmonella. Emerg Microbes Infect. 14:24758382025. View Article : Google Scholar : PubMed/NCBI

23 

Moreno-Yruela C, Zhang D, Wei W, Bæk M, Liu W, Gao J, Danková D, Nielsen AL, Bolding JE, Yang L, et al: Class I histone deacetylases (HDAC1-3) are histone lysine delactylases. Sci Adv. 8:eabi66962022. View Article : Google Scholar : PubMed/NCBI

24 

Gonzatti MB, Hintzen JCJ, Sharma I, Najar MA, Tsusaka T, Marcinkiewicz MM, Da Silva Crispim CV, Snyder NW, Burslem GM and Goldberg EL: Class I histone deacetylases catalyze lysine lactylation. J Biol Chem. 301:1106022025. View Article : Google Scholar : PubMed/NCBI

25 

Tsusaka T, Najar MA, Sharma I, Marcinkiewicz MM, Crispim CVDS, Snyder NW, Burslem GM and Goldberg EL: Class I histone deacetylases catalyze lysine lactylation. bioRxiv [Preprint]. 2025.02.25.640220. 2025.

26 

Nickel GA, Pederson NJ, Faheem, Yang Z, Bulf J and Diehl KL: Sirtuin 6 is a histone delactylase. J Biol Chem. 301:1107952025. View Article : Google Scholar : PubMed/NCBI

27 

Chen C, Zhang Y, Zang Y, Fan Z, Han Y, Bai X, Wang A, Zhang J, Wang J and Zhang K: SIRT3 functions as an eraser of histone H3K9 lactylation to modulate transcription for inhibiting the progression of esophageal cancer. Mol Cell Proteomics. 24:1009732025. View Article : Google Scholar : PubMed/NCBI

28 

Zou L, Liu Z, Peng L, Wu B, Huang Y, Wen X, Han D, Tan W and Zhou Y: Delactylation of H3K9 by Sirtuin6 inhibits MGMT transcription and reverses temozolomide resistance in glioblastoma. Int J Biol Macromol. 327:1473322025. View Article : Google Scholar : PubMed/NCBI

29 

Jin J, Bai L, Wang D, Ding W, Cao Z, Yan P, Li Y, Xi L, Wang Y, Zheng X, et al: SIRT3-dependent delactylation of cyclin E2 prevents hepatocellular carcinoma growth. EMBO Rep. 24:e560522023. View Article : Google Scholar : PubMed/NCBI

30 

He X, Li Y, Li J, Li Y, Chen S, Yan X, Xie Z, Du J, Chen G, Song J and Mei Q: HDAC2-mediated METTL3 delactylation promotes DNA damage repair and chemotherapy resistance in triple-negative breast cancer. Adv Sci (Weinh). 12:e24131212025. View Article : Google Scholar : PubMed/NCBI

31 

Nuñez R, Sidlowski PFW, Steen EA, Wynia-Smith SL, Sprague DJ, Keyes RF and Smith BC: The TRIM33 bromodomain recognizes histone lysine lactylation. ACS Chem Biol. 19:2418–2428. 2024. View Article : Google Scholar : PubMed/NCBI

32 

Zhai G, Niu Z, Jiang Z, Zhao F, Wang S, Chen C, Zheng W, Wang A, Zang Y, Han Y and Zhang K: DPF2 reads histone lactylation to drive transcription and tumorigenesis. Proc Natl Acad Sci USA. 121:e24214961212024. View Article : Google Scholar : PubMed/NCBI

33 

Wei E, Ji D, Jia Y, Sun Z, Gao C, Zeng C, Wang C, Yu M, Shang G, Xie L, et al: BRD9 recognizes lactate-induced H3K18 lactylation to drive oncogenic chromatin remodeling in hepatocellular carcinoma. Cell Death Differ. 33:1946–1959. 2026. View Article : Google Scholar : PubMed/NCBI

34 

Bao Q, Wan N, He Z, Cao J, Yuan W, Hao H and Ye H: Subcellular proteomic mapping of lysine lactylation. J Am Soc Mass Spectrom. 35:3221–3232. 2024. View Article : Google Scholar : PubMed/NCBI

35 

He Y, Ji Z, Gong Y, Fan L, Xu P, Chen X, Miao J, Zhang K, Zhang W, Ma P, et al: Numb/Parkin-directed mitochondrial fitness governs cancer cell fate via metabolic regulation of histone lactylation. Cell Rep. 42:1120332023. View Article : Google Scholar : PubMed/NCBI

36 

Mao Y, Zhang J, Zhou Q, He X, Zheng Z, Wei Y, Zhou K, Lin Y, Yu H, Zhang H, et al: Hypoxia induces mitochondrial protein lactylation to limit oxidative phosphorylation. Cell Res. 34:13–30. 2024. View Article : Google Scholar : PubMed/NCBI

37 

Huang B, Jin M, Cui G, Wang Z, Wang F, Chen M, Zhu L, Li Y, Yang X, Li R, et al: GCN5-ERK lactylation-phosphorylation loop amplifies lactate-driven cancer progression. Nat Chem Biol. 22:634–648. 2026. View Article : Google Scholar : PubMed/NCBI

38 

Sun S, Xu Z, He L, Shen Y, Yan Y, Lv X, Zhu X, Li W, Tian WY, Zheng Y, et al: Metabolic regulation of cytoskeleton functions by HDAC6-catalyzed α-tubulin lactylation. Nat Commun. 15:83772024. View Article : Google Scholar

39 

Zhou J, Qiu S, Yang X, Wu Y, Yao X, Hu H, Luo J, Wijaya CS, Ma L, Long X, et al: Hypoxia-Induced PRMT1 lactylation drives vimentin arginine asymmetric dimethylation in tumor metastasis. Adv Sci (Weinh). 12:e098612025. View Article : Google Scholar : PubMed/NCBI

40 

Jiang J, Huang D, Jiang Y, Hou J, Tian M, Li J, Sun L, Zhang Y, Zhang T, Li Z, et al: Lactate modulates cellular metabolism through histone lactylation-mediated gene expression in non-small cell lung cancer. Front Oncol. 11:6475592021. View Article : Google Scholar : PubMed/NCBI

41 

Sharma NK and Pal JK: Metabolic ink lactate modulates epigenomic landscape: A concerted role of pro-tumor microenvironment and macroenvironment during carcinogenesis. Curr Mol Med. 21:177–181. 2021. View Article : Google Scholar

42 

Gu J, Zhou J, Chen Q, Xu X, Gao J, Li X, Shao Q, Zhou B, Zhou H, Wei S, et al: Tumor metabolite lactate promotes tumorigenesis by modulating MOESIN lactylation and enhancing TGF-β signaling in regulatory T cells. Cell Rep. 39:1109862022. View Article : Google Scholar

43 

Yang D, Yin J, Shan L, Yi X, Zhang W and Ding Y: Identification of lysine-lactylated substrates in gastric cancer cells. iScience. 25:1046302022. View Article : Google Scholar : PubMed/NCBI

44 

Hong H, Chen X, Wang H, Gu X, Yuan Y and Zhang Z: Global profiling of protein lysine lactylation and potential target modified protein analysis in hepatocellular carcinoma. Proteomics. 23:e22004322023. View Article : Google Scholar : PubMed/NCBI

45 

Huang Y, Luo G, Peng K, Song Y, Wang Y, Zhang H, Li J, Qiu X, Pu M, Liu X, et al: Lactylation stabilizes TFEB to elevate autophagy and lysosomal activity. J Cell Biol. 223:e2023080992024. View Article : Google Scholar : PubMed/NCBI

46 

Jing F, Zhu L, Zhang J, Zhou X, Bai J, Li X, Zhang H and Li T: Multi-omics reveals lactylation-driven regulatory mechanisms promoting tumor progression in oral squamous cell carcinoma. Genome Biol. 25:2722024. View Article : Google Scholar : PubMed/NCBI

47 

Meng Q, Sun H, Zhang Y, Yang X, Hao S, Liu B, Zhou H, Xu ZX and Wang Y: Lactylation stabilizes DCBLD1 activating the pentose phosphate pathway to promote cervical cancer progression. J Exp Clin Cancer Res. 43:362024. View Article : Google Scholar : PubMed/NCBI

48 

Luo Y, Yang Z, Yu Y and Zhang P: HIF1α lactylation enhances KIAA1199 transcription to promote angiogenesis and vasculogenic mimicry in prostate cancer. Int J Biol Macromol. 222:2225–2243. 2022. View Article : Google Scholar : PubMed/NCBI

49 

Yang J, Luo L, Zhao C, Li X, Wang Z, Zeng Z, Yang X, Zheng X, Jie H, Kang L, et al: A positive feedback loop between inactive VHL-Triggered histone lactylation and PDGFRβ signaling drives clear cell renal cell carcinoma progression. Int J Biol Sci. 18:3470–3483. 2022. View Article : Google Scholar

50 

Wang X, Ying T, Yuan J, Wang Y, Su X, Chen S, Zhao Y, Zhao Y, Sheng J, Teng L, et al: BRAFV600E restructures cellular lactylation to promote anaplastic thyroid cancer proliferation. Endocr Relat Cancer. 30:e2203442023. View Article : Google Scholar : PubMed/NCBI

51 

Zhang C, Yu R, Li S, Yuan M, Hu T, Liu J, Ke H, Ye S, Yun J, Huang J, et al: KRAS mutation increases histone H3 lysine 9 lactylation (H3K9la) to promote colorectal cancer progression by facilitating cholesterol transporter GRAMD1A expression. Cell Death Differ. 32:2225–2238. 2025. View Article : Google Scholar : PubMed/NCBI

52 

Gao J, Liu R, Huang K, Li Z, Sheng X, Chakraborty K, Han C, Zhang D, Becker L and Zhao Y: Dynamic investigation of hypoxia-induced L-lactylation. Proc Natl Acad Sci USA. 122:e24048991222025. View Article : Google Scholar : PubMed/NCBI

53 

Zang Y, Wang A, Zhang J, Xia M, Jiang Z, Jia B, Lu C, Chen C, Wang S, Zhang Y, et al: Hypoxia promotes histone H3K9 lactylation to enhance LAMC2 transcription in esophageal squamous cell carcinoma. iScience. 27:1101882024. View Article : Google Scholar : PubMed/NCBI

54 

Miao Z, Zhao X and Liu X: Hypoxia induced β-catenin lactylation promotes the cell proliferation and stemness of colorectal cancer through the wnt signaling pathway. Exp Cell Res. 422:1134392023. View Article : Google Scholar

55 

Xiong J, He J, Zhu J, Pan J, Liao W, Ye H, Wang H, Song Y, Du Y, Cui B, et al: Lactylation-driven METTL3-mediated RNA m(6)A modification promotes immunosuppression of tumor-infiltrating myeloid cells. Mol Cell. 82:1660–1677.e10. 2022. View Article : Google Scholar : PubMed/NCBI

56 

Cai J, Zhang P, Cai Y, Zhu G, Chen S, Song L, Du J, Wang B, Dai W, Zhou J, et al: Lactylation-Driven NUPR1 Promotes Immunosuppression of Tumor-Infiltrating Macrophages in Hepatocellular Carcinoma. Adv Sci (Weinh). 12:e24130952025. View Article : Google Scholar : PubMed/NCBI

57 

Huang ZW, Zhang XN, Zhang L, Liu LL, Zhang JW, Sun YX, Xu JQ, Liu Q and Long ZJ: STAT5 promotes PD-L1 expression by facilitating histone lactylation to drive immunosuppression in acute myeloid leukemia. Signal Transduct Target Ther. 8:3912023. View Article : Google Scholar : PubMed/NCBI

58 

De Leo A, Ugolini A, Yu X, Scirocchi F, Scocozza D, Peixoto B, Pace A, D'Angelo L, Liu JKC, Etame AB, et al: Glucose-driven histone lactylation promotes the immunosuppressive activity of monocyte-derived macrophages in glioblastoma. Immunity. 57:1105–1123.e8. 2024. View Article : Google Scholar : PubMed/NCBI

59 

Li Z, Liang P, Chen Z, Chen Z, Jin T, He F, Chen X and Yang K: CAF-secreted LOX promotes PD-L1 expression via histone Lactylation and regulates tumor EMT through TGFβ/IGF1 signaling in gastric cancer. Cell Signal. 124:1114622024. View Article : Google Scholar

60 

Kong W, He J, Zhou Q, Zhou X, Wei X, Yang Y, Mei Y, Wang S, Zhang X, Yao B, et al: Histone lactylation-related genes correlate with the molecular patterns and functions of cancer-associated fibroblasts and have significant clinical implications in clear cell renal cell carcinoma. Heliyon. 10:e335542024. View Article : Google Scholar : PubMed/NCBI

61 

He J, Li W, Wang S, Lan J, Hong X, Liao L, Kang D, Wang W, Wang R, Zhang W, et al: Cancer associated fibroblasts-derived lactate induces oxaliplatin treatment resistance by promoting cancer stemness via ANTXR1 lactylation in colorectal cancer. Cancer Lett. 631:2179172025. View Article : Google Scholar : PubMed/NCBI

62 

Zhang C, Zhou W, Xu H, Xu J, Li J, Liu X, Lu X, Dai J, Jiang Y, Wang W, et al: Cancer-associated fibroblasts promote EGFR-TKI resistance via the CTHRC1/glycolysis/H3K18la positive feedback loop. Oncogene. 44:1400–1414. 2025. View Article : Google Scholar : PubMed/NCBI

63 

Li L, Li Z, Meng X, Wang X, Song D, Liu Y, Xu T, Qin J, Sun N, Tian K, et al: Histone lactylation-derived LINC01127 promotes the self-renewal of glioblastoma stem cells via the cis-regulating the MAP4K4 to activate JNK pathway. Cancer Lett. 579:2164672023. View Article : Google Scholar : PubMed/NCBI

64 

Pan L, Feng F, Wu J, Fan S, Han J, Wang S, Yang L, Liu W, Wang C and Xu K: Demethylzeylasteral targets lactate by inhibiting histone lactylation to suppress the tumorigenicity of liver cancer stem cells. Pharmacol Res. 181:1062702022. View Article : Google Scholar : PubMed/NCBI

65 

Zhang X, Li Y and Chen Y: Development of a comprehensive gene signature linking hypoxia, glycolysis, lactylation, and metabolomic insights in gastric cancer through the integration of bulk and single-cell RNA-Seq data. Biomedicines. 11:29482023. View Article : Google Scholar : PubMed/NCBI

66 

Lu X, Zhou Z, Qiu P and Xin T: Integrated single-cell and bulk RNA-sequencing data reveal molecular subtypes based on lactylation-related genes and prognosis and therapeutic response in glioma. Heliyon. 10:e307262024. View Article : Google Scholar : PubMed/NCBI

67 

Yu Y, Li Y, Zhou L, Cheng X and Gong Z: Hepatic stellate cells promote hepatocellular carcinoma development by regulating histone lactylation: Novel insights from single-cell RNA sequencing and spatial transcriptomics analyses. Cancer Lett. 604:2172432024. View Article : Google Scholar : PubMed/NCBI

68 

Han R, Chi G, Sun D, Xu Z, Zhou L and Xu K: Single-cell and spatial transcriptomics reveal lactylation-associated tumor cell clusters and define a prognostic risk model in glioblastoma. BMC Cancer. 25:19012025. View Article : Google Scholar : PubMed/NCBI

69 

Li F, Zhang H, Huang Y, Li D, Zheng Z, Xie K, Cao C, Wang Q, Zhao X, Huang Z, et al: Single-cell transcriptome analysis reveals the association between histone lactylation and cisplatin resistance in bladder cancer. Drug Resist Updat. 73:1010592024. View Article : Google Scholar : PubMed/NCBI

70 

Li J, Tang C, Zhang X, Xing R and Guo Q: Histone Lactylation-Driven Upregulation of VRK1 Expression Promotes Stemness and Proliferation of Glioma Stem Cells. Adv Sci (Weinh). 12:e038972025. View Article : Google Scholar : PubMed/NCBI

71 

Liu Z, Han J, Su S, Zeng Q, Wu Z, Yuan J and Yang J: Histone lactylation facilitates MCM7 expression to maintain stemness and radio-resistance in hepatocellular carcinoma. Biochem Pharmacol. 236:1168872025. View Article : Google Scholar : PubMed/NCBI

72 

Zhang Q, Han Z, Liu JH, Li M, Li W, Zhou X and Liu X: Hypoxia facilitates stemness of colon cancer cells via histone lactylation. Biochim Biophys Acta Mol Basis Dis. 1871:1679932025. View Article : Google Scholar : PubMed/NCBI

73 

Nguyen NTB, Gevers S, Kok RNU, Burgering LM, Neikes H, Akkerman N, Betjes MA, Ludikhuize MC, Gulersonmez C, Stigter ECA, et al: Lactate controls cancer stemness and plasticity through epigenetic regulation. Cell Metab. 37:903–919.e10. 2025. View Article : Google Scholar : PubMed/NCBI

74 

Qiao Z, Li Y, Li S, Liu S and Cheng Y: Hypoxia-induced SHMT2 protein lactylation facilitates glycolysis and stemness of esophageal cancer cells. Mol Cell Biochem. 479:3063–3076. 2024. View Article : Google Scholar : PubMed/NCBI

75 

Li Q, Lin G, Zhang K, Liu X, Li Z, Bing X, Nie Z, Jin S, Guo J and Min X: Hypoxia exposure induces lactylation of Axin1 protein to promote glycolysis of esophageal carcinoma cells. Biochem Pharmacol. 226:1164152024. View Article : Google Scholar : PubMed/NCBI

76 

Yan F, Teng Y, Li X, Zhong Y, Li C, Yan F and He X: Hypoxia promotes non-small cell lung cancer cell stemness, migration, and invasion via promoting glycolysis by lactylation of SOX9. Cancer Biol Ther. 25:23041612024. View Article : Google Scholar : PubMed/NCBI

77 

Zhao S, Cheng J, Zhou G, Tao L, Xing J, Liu L, Chen Z and Song P: Histone lactylation-driven YTHDF2 promotes non-small cell lung cancer cell glycolysis and stemness by recognizing m6A modification of SFRP2. Biochem Pharmacol. 240:1170972025. View Article : Google Scholar : PubMed/NCBI

78 

Yuan Q, Zhang H, Zhang N, Qian Y, Hong Z, Wan X, Ye R, Chen D, Feng X, Yu G and Niu M: BPHL promotes TNBC stemness by resolving R-loops via POLR2A lactylation inhibition and BARD1-mediated ubiquitination. Cancer Lett. 645:2183882026. View Article : Google Scholar : PubMed/NCBI

79 

Fiaschi T, Giannoni E, Taddei ML, Cirri P, Marini A, Pintus G, Nativi C, Richichi B, Scozzafava A, Carta F, et al: Carbonic anhydrase IX from cancer-associated fibroblasts drives epithelial-mesenchymal transition in prostate carcinoma cells. Cell Cycle. 12:1791–1801. 2013. View Article : Google Scholar : PubMed/NCBI

80 

Chen S, Huang G, Guo Z, Guo Z, Cao C, Zhao G, Lubamba GP, Huang Y, Yang J, Lian H, et al: Tumor-associated Schwann cells promote salivary adenoid cystic carcinoma stem-like reprogramming via IGF2/IGF1R induced histone H3 lysine 18 lactylation. Cancer Lett. 628:2178472025. View Article : Google Scholar : PubMed/NCBI

81 

Shi L, Li B, Tan J, Zhu L, Zhang S, Zhang Y, Xiang M, Li J, Chen Y, Han X, et al: Exosomal lncRNA Mir100hg from lung cancer stem cells activates H3K14 lactylation to enhance metastatic activity in non-stem lung cancer cells. J Nanobiotechnology. 23:1562025. View Article : Google Scholar : PubMed/NCBI

82 

Wang D, Du G, Chen X, Wang J, Liu K, Zhao H, Cheng C, He Y, Jing N, Xu P, et al: Zeb1-controlled metabolic plasticity enables remodeling of chromatin accessibility in the development of neuroendocrine prostate cancer. Cell Death Differ. 31:779–791. 2024. View Article : Google Scholar : PubMed/NCBI

83 

Zhou Z, Yin X, Sun H, Lu J, Li Y, Fan Y, Lv P, Han M, Wu J, Li S, et al: PTBP1 Lactylation Promotes Glioma Stem Cell Maintenance through PFKFB4-Driven Glycolysis. Cancer Res. 85:739–757. 2025. View Article : Google Scholar

84 

Tang X, Liu Y, Yang C, Zhang H, Zhang G, Wang Q, Jiang S, Gao X, Liu Y and Dong Y: Deciphering the lactylation landscape in glioma: a novel gene signature predicts patient survival and immunotherapy sensitivity. Front Immunol. 16:16643472025. View Article : Google Scholar : PubMed/NCBI

85 

Yao G and Yang Z: Glypican-3 knockdown inhibits the cell growth, stemness, and glycolysis development of hepatocellular carcinoma cells under hypoxic microenvironment through lactylation. Arch Physiol Biochem. 130:546–554. 2024.

86 

Liu Y, Chen J, Ma L, Zhao S, Hui X, Xiong W, Cheng S and Zhang Y: ZMIZ1 lactylation induces tamoxifen resistance in breast cancer through increasing transcriptional activity of Nanog to impact cell stemness and cholesterol uptake. Cell Biol Toxicol. 41:1172025. View Article : Google Scholar : PubMed/NCBI

87 

Deng J, Li Y, Yin L, Liu S, Li Y, Liao W, Mu L, Luo X and Qin J: Histone lactylation enhances GCLC expression and thus promotes chemoresistance of colorectal cancer stem cells through inhibiting ferroptosis. Cell Death Dis. 16:1932025. View Article : Google Scholar : PubMed/NCBI

88 

Zhao Y, Liu W, Deng K, Chen Y, Zhou P, Liu C, Jiang G, Wu J, Zhang Y, Qu H, et al: LncRNA BASP1-AS1 drives PCBP2 K115 lactylation to suppress ferroptosis and confer oxaliplatin resistance in gastric cancer. Free Radic Biol Med. 240:717–734. 2025. View Article : Google Scholar : PubMed/NCBI

89 

Gao M, Wang S, Huang Z, Wang T and Yu Y: H3K18la Facilitates TRA2A-Mediated alternative splicing of STIL, suppressing ferroptosis and cisplatin treatment sensitivity in ovarian cancer. Cancer Res Treat. 58:1428–1448. 2026. View Article : Google Scholar :

90 

Sun C, Li X, Teng Q, Liu X, Song L, Schiöth HB, Wu H, Ma X, Zhang Z, Qi C, et al: Targeting platinum-resistant ovarian cancer by disrupting histone and RAD51 lactylation. Theranostics. 15:3055–3075. 2025. View Article : Google Scholar : PubMed/NCBI

91 

Yue Q, Wang Z, Shen Y, Lan Y, Zhong X, Luo X, Yang T, Zhang M, Zuo B, Zeng T, et al: Histone H3K9 lactylation confers temozolomide resistance in glioblastoma via LUC7L2-Mediated MLH1 intron retention. Adv Sci (Weinh). 11:e23092902024. View Article : Google Scholar : PubMed/NCBI

92 

Dai J, Lu X, Zhang C, Qu T, Li W, Su J, Guo R, Yin D, Wu P, Han L and Zhang E: NNMT promotes acquired EGFR-TKI resistance by forming EGR1 and lactate-mediated double positive feedback loops in non-small cell lung cancer. Mol Cancer. 24:792025. View Article : Google Scholar : PubMed/NCBI

93 

Li A, Gong Z, Long Y, Li Y, Liu C, Lu X, Li Q, He X, Lu H, Wu K, et al: Lactylation of LSD1 is an acquired epigenetic vulnerability of BRAFi/MEKi-resistant melanoma. Dev Cell. 60:1974–1990.e11. 2025. View Article : Google Scholar : PubMed/NCBI

94 

Lu Y, Zhu J, Zhang Y, Li W, Xiong Y, Fan Y, Wu Y, Zhao J, Shang C, Liang H and Zhang W: Lactylation-Driven IGF2BP3-Mediated serine metabolism reprogramming and RNA m6A-Modification promotes lenvatinib resistance in HCC. Adv Sci (Weinh). 11:e24013992024. View Article : Google Scholar : PubMed/NCBI

95 

Dong R, Fei Y, He Y, Gao P, Zhang B, Zhu M, Wang Z, Wu L, Wu S, Wang X, et al: Lactylation-Driven HECTD2 Limits the Response of Hepatocellular Carcinoma to Lenvatinib. Adv Sci (Weinh). 12:e24125592025. View Article : Google Scholar : PubMed/NCBI

96 

Zeng Y, Jiang H, Chen Z, Xu J, Zhang X, Cai W, Zeng X, Ma P, Lin R, Yu H, et al: Histone lactylation promotes multidrug resistance in hepatocellular carcinoma by forming a positive feedback loop with PTEN. Cell Death Dis. 16:592025. View Article : Google Scholar : PubMed/NCBI

97 

Chen HJ, Yu MM, Huang JC, Lan FY, Liao HH, Xu ZH, Yu YJ, Huang YC and Chen F: SLC4A4 is a novel driver of enzalutamide resistance in prostate cancer. Cancer Lett. 597:2170702024. View Article : Google Scholar : PubMed/NCBI

98 

Sun R, Huang Y, He H, Li Q, Wang L, Zhang G, Wei Z, Cao Y, Li J, Wang X, et al: KDM5B-driven glucose metabolic reprogramming promotes enzalutamide resistance in prostate cancer via the lactate/hnRNPA1 lactylation/AR-V7 axis. Mol Cancer. 25:972026. View Article : Google Scholar

99 

Tong H, Jiang Z, Song L, Tan K, Yin X, He C, Huang J, Li X, Jing X, Yun H, et al: Dual impacts of serine/glycine-free diet in enhancing antitumor immunity and promoting evasion via PD-L1 lactylation. Cell Metab. 38:2472026. View Article : Google Scholar

100 

Liu S, Pan Y, Liu W, Bu X, Shao R, Wang Q, Wu J, Wu C, Hu W, Xu J, et al: Lactylation-driven MVP upregulation boosts immunotherapy resistance by inhibiting PD-L1 degradation in hepatocellular carcinoma. J Immunother Cancer. 13:e0122302025. View Article : Google Scholar : PubMed/NCBI

101 

Chen Q, Yuan H, Bronze MS and Li M: Targeting lactylation and the STAT3/CCL2 axis to overcome immunotherapy resistance in pancreatic ductal adenocarcinoma. J Clin Invest. 135:e1914222025. View Article : Google Scholar : PubMed/NCBI

102 

Sun K, Zhang X, Shi J, Huang J, Wang S, Li X, Lin H, Zhao D, Ye M, Zhang S, et al: Elevated protein lactylation promotes immunosuppressive microenvironment and therapeutic resistance in pancreatic ductal adenocarcinoma. J Clin Invest. 135:e1870242025. View Article : Google Scholar : PubMed/NCBI

103 

Wang R, Li C, Cheng Z, Li M, Shi J, Zhang Z, Jin S and Ma H: H3K9 lactylation in malignant cells facilitates CD8(+) T cell dysfunction and poor immunotherapy response. Cell Rep. 43:1146862024. View Article : Google Scholar

104 

Zhang C, Zhou L, Zhang M, Du Y, Li C, Ren H and Zheng L: H3K18 Lactylation potentiates immune escape of non-small cell lung cancer. Cancer Res. 84:3589–3601. 2024. View Article : Google Scholar : PubMed/NCBI

105 

Chao J, Chen GD, Huang ST, Gu H, Liu YY, Luo Y, Lin Z, Chen ZZ, Li X, Zhang B, et al: High histone H3K18 lactylation level is correlated with poor prognosis in epithelial ovarian cancer. Neoplasma. 71:319–332. 2024. View Article : Google Scholar : PubMed/NCBI

106 

Zhao Y, Xing Z, Zhao Y, Xu H, Liu R, Yang T, Wang Y and Zhu X: Lactylation prognostic signature identifies DHCR7 as a modulator of chemoresistance and immunotherapy efficacy in bladder cancer. Front Immunol. 16:15857272025. View Article : Google Scholar : PubMed/NCBI

107 

Yang X, Li G, Jiang R, Yang Y, Zhu H, Huang L, Li T, Zhou J and Liu Z: Lactylation-related gene signatures for prognosis and treatment response prediction in radiation-resistant non-small cell lung cancer. Discov Oncol. 16:17872025. View Article : Google Scholar : PubMed/NCBI

108 

Hu H, Peng F, Ba Q, Hu W and Lu Y: Integrative machine learning identifies lactylation-related gene signature prognostic for chemotherapeutic efficacy in colorectal carcinoma. Discov Oncol. 17:692025. View Article : Google Scholar : PubMed/NCBI

109 

Chen Y, Wu J, Zhai L, Zhang T, Yin H, Gao H, Zhao F, Wang Z, Yang X, Jin M, et al: Metabolic regulation of homologous recombination repair by MRE11 lactylation. Cell. 187:294–311.e21. 2024. View Article : Google Scholar

110 

Yang Z, Su W, Zhang Q, Niu L, Feng B, Zhang Y, Huang F, He J, Zhou Q, Zhou X, et al: Lactylation of HDAC1 confers resistance to ferroptosis in colorectal cancer. Adv Sci (Weinh). 12:e24088452025. View Article : Google Scholar : PubMed/NCBI

111 

Fu Q, Cat A and Zheng YG: New histone lysine acylation biomarkers and their roles in epigenetic regulation. Curr Protoc. 3:e7462023. View Article : Google Scholar : PubMed/NCBI

112 

Sun L, Zhang Y, Yang B, Sun S, Zhang P, Luo Z, Feng T, Cui Z, Zhu T, Li Y, et al: Lactylation of METTL16 promotes cuproptosis via m(6)A-modification on FDX1 mRNA in gastric cancer. Nat Commun. 14:65232023. View Article : Google Scholar : PubMed/NCBI

113 

Rao K, Zhang X, Luo Y, Xia Q, Jin Y and He J: Lactylation orchestrates ubiquitin-independent degradation of cGAS and promotes tumor growth. Cell Rep. 44:1154412025. View Article : Google Scholar : PubMed/NCBI

114 

Lao Y, Jin Y, Wu S, Fang T, Wang Q, Sun L and Sun B: Deciphering a profiling based on multiple post-translational modifications functionally associated regulatory patterns and therapeutic opportunities in human hepatocellular carcinoma. Mol Cancer. 23:2832024. View Article : Google Scholar : PubMed/NCBI

115 

Chen S, Li Y, Hu J, Li H, Hu C, Zhao J, Qian H, Bai S, Tang Z and Feng Y: Integrating bulk RNA-seq, scRNA-seq, and spatial transcriptomics data to identify novel post-translational modification-related molecular subtypes and therapeutic responses in hepatocellular carcinoma. Cancer Cell Int. 25:3302025. View Article : Google Scholar : PubMed/NCBI

116 

Krishnamoorthy G, Kaiser P, Abu Abed U, Weiner J III, Moura-Alves P, Brinkmann V and Kaufmann SHE: FX11 limits Mycobacterium tuberculosis growth and potentiates bactericidal activity of isoniazid through host-directed activity. Dis Model Mech. 13:dmm0419542020. View Article : Google Scholar : PubMed/NCBI

117 

Sun T, Liu B, Li Y, Wu J, Cao Y, Yang S, Tan H, Cai L, Zhang S, Qi X, et al: Oxamate enhances the efficacy of CAR-T therapy against glioblastoma via suppressing ectonucleotidases and CCR8 lactylation. J Exp Clin Cancer Res. 42:2532023. View Article : Google Scholar : PubMed/NCBI

118 

Ge H, Malsiu F, Gao Y, Losmanova T, Blank F, Ott J, Medová M, Peng RW, Deng H, Dorn P and Marti TM: Inhibition of LDHB suppresses the metastatic potential of lung cancer by reducing mitochondrial GSH catabolism. Cancer Lett. 611:2173532025. View Article : Google Scholar

119 

Lopez E, Karattil R, Nannini F, Weng-Kit Cheung G, Denzler L, Galvez-Cancino F, Quezada S and Pule MA: Inhibition of lactate transport by MCT-1 blockade improves chimeric antigen receptor T-cell therapy against B-cell malignancies. J Immunother Cancer. 11:e0062872023. View Article : Google Scholar : PubMed/NCBI

120 

Saulle E, Spinello I, Quaranta MT, Pasquini L, Pelosi E, Iorio E, Castelli G, Chirico M, Pisanu ME, Ottone T, et al: Targeting lactate metabolism by inhibiting MCT1 or MCT4 impairs leukemic cell proliferation, induces two different related death-pathways and increases chemotherapeutic sensitivity of acute myeloid leukemia cells. Front Oncol. 10:6214582021. View Article : Google Scholar : PubMed/NCBI

121 

Bridgewater HE, Bolitho EM, Romero-Canelón I, Sadler PJ and Coverdale JPC: Targeting cancer lactate metabolism with synergistic combinations of synthetic catalysts and monocarboxylate transporter inhibitors. J Biol Inorg Chem. 28:345–353. 2023. View Article : Google Scholar : PubMed/NCBI

122 

Chen ZX, Liu MD, Guo DK, Zou MZ, Wang SB, Cheng H, Zhong Z and Zhang XZ: A MSN-based tumor-targeted nanoplatform to interfere with lactate metabolism to induce tumor cell acidosis for tumor suppression and anti-metastasis. Nanoscale. 12:2966–2972. 2020. View Article : Google Scholar : PubMed/NCBI

123 

Hu M, Zhao Y, Cao Y, Tang Q, Feng Z, Ni J and Zhou X: DRP1 promotes lactate utilization in KRAS-mutant non-small-cell lung cancer cells. Cancer Sci. 111:3588–3599. 2020. View Article : Google Scholar : PubMed/NCBI

124 

Khamoui AV, Tokmina-Roszyk D, Rossiter HB, Fields GB and Visavadiya NP: Hepatic proteome analysis reveals altered mitochondrial metabolism and suppressed acyl-CoA synthetase-1 in colon-26 tumor-induced cachexia. Physiol Genomics. 52:203–216. 2020. View Article : Google Scholar : PubMed/NCBI

125 

Zeng Z, Lan J, Lei S, Yang Y, He Z, Xue Y and Chen T: Simultaneous inhibition of ornithine decarboxylase 1 and pyruvate kinase M2 exerts synergistic effects against hepatocellular carcinoma cells. Onco Targets Ther. 13:11697–11709. 2020. View Article : Google Scholar : PubMed/NCBI

126 

Qin X, Zhang M, Hu X, Du Q, Zhao Z, Jiang Y and Luan Y: Nanoengineering of a newly designed chlorin e6 derivative for amplified photodynamic therapy via regulating lactate metabolism. Nanoscale. 13:11953–11962. 2021. View Article : Google Scholar : PubMed/NCBI

127 

Zhang Y, Li L, Li Y, Fei Y, Xue C, Yao X, Zhao Y, Wang X, Li M and Luo Z: An ROS-activatable nanoassembly remodulates tumor cell metabolism for enhanced ferroptosis therapy. Adv Healthc Mater. 11:e21017022022. View Article : Google Scholar

128 

Zhang F, Gu T, Li J, Zhu Y, Chu M, Zhou Q and Liu J: Emodin regulated lactate metabolism by inhibiting MCT1 to delay non-small cell lung cancer progression. Hum Cell. 38:112024. View Article : Google Scholar : PubMed/NCBI

129 

Xu H, Li L, Wang S, Wang Z, Qu L, Wang C and Xu K: Royal jelly acid suppresses hepatocellular carcinoma tumorigenicity by inhibiting H3 histone lactylation at H3K9la and H3K14la sites. Phytomedicine. 118:1549402023. View Article : Google Scholar : PubMed/NCBI

130 

Yu Y, Huang X, Liang C and Zhang P: Evodiamine impairs HIF1A histone lactylation to inhibit Sema3A-mediated angiogenesis and PD-L1 by inducing ferroptosis in prostate cancer. Eur J Pharmacol. 957:1760072023. View Article : Google Scholar : PubMed/NCBI

131 

Li M, Zhu T, Jiang F, Zhang W, Gao Y, Shen M, Yu J and Zheng J: Ginsenoside Rk1 suppresses the epithelial-mesenchymal transition of hepatic stellate cells via PFKFB2-mediated aerobic glycolysis. Chem Biol Interact. 421:1117602025. View Article : Google Scholar : PubMed/NCBI

132 

Kumstel S, Schreiber T, Goldstein L, Stenzel J, Lindner T, Joksch M, Zhang X, Wendt EHU, Schönrogge M, Krause B, et al: Targeting pancreatic cancer with combinatorial treatment of CPI-613 and inhibitors of lactate metabolism. PLoS One. 17:e02666012022. View Article : Google Scholar : PubMed/NCBI

133 

Zhang Y, Wu X, Wang K, Tang Y, Lu X, Sun F, Tang H, Chen X and Ning S: Simultaneous reversal of T lymphocytes and cancer cells metabolism via a biomimetic heavy-atom-free photosensitizers-based combination therapies to boost cancer photoimmunotherapy. Adv Sci (Weinh). 12:e24161432025. View Article : Google Scholar : PubMed/NCBI

134 

Deng X, Zhu Y, Dai Z, Liu Q, Song Z, Liu T, Huang Y and Chen H: A Bimetallic Nanomodulator to Reverse Immunosuppression via Sonodynamic-Ferroptosis and Lactate Metabolism Modulation. Small. 20:e24045802024. View Article : Google Scholar : PubMed/NCBI

135 

Li Y, Wei Y, Ma S, Li F, Meng X and Yu S: A dual-transformable MgGa-MOF nanoplatform for HCC therapy via lactate metabolism blockade and immune reactivation. J Nanobiotechnology. 24:4522026. View Article : Google Scholar : PubMed/NCBI

136 

Cheng Z, Huang H, Li M, Liang X, Tan Y and Chen Y: Lactylation-related gene signature effectively predicts prognosis and treatment responsiveness in hepatocellular carcinoma. Pharmaceuticals (Basel). 16:6442023. View Article : Google Scholar : PubMed/NCBI

137 

Xie B, Lin J, Chen X, Zhou X, Zhang Y, Fan M, Xiang J, He N, Hu Z and Wang F: CircXRN2 suppresses tumor progression driven by histone lactylation through activating the Hippo pathway in human bladder cancer. Mol Cancer. 22:1512023. View Article : Google Scholar : PubMed/NCBI

138 

Wu Q, Li X, Long M, Xie X and Liu Q: Integrated analysis of histone lysine lactylation (Kla)-specific genes suggests that NR6A1, OSBP2 and UNC119B are novel therapeutic targets for hepatocellular carcinoma. Sci Rep. 13:186422023. View Article : Google Scholar : PubMed/NCBI

139 

Wu X: In-depth discovery of protein lactylation in hepatocellular carcinoma. Proteomics,. 23:e23000032023. View Article : Google Scholar : PubMed/NCBI

140 

Shao C, Tang S, Yu S, Liu C, Zhang Y, Wan T, He Z, Yuan Q, Wu S, Zhang H, et al: Genetic code expansion reveals site-specific lactylation in living cells reshapes protein functions. Nat Commun. 16:2272025. View Article : Google Scholar : PubMed/NCBI

141 

Wang X, Liu X, Xiao R, Fang Y, Zhou F, Gu M, Luo X, Jiang D, Tang Y, You L and Zhao Y: Histone lactylation dynamics: Unlocking the triad of metabolism, epigenetics, and immune regulation in metastatic cascade of pancreatic cancer. Cancer Lett. 598:2171172024. View Article : Google Scholar : PubMed/NCBI

142 

Chen B, Deng Y, Hong Y, Fan L, Zhai X, Hu H, Yin S, Chen Q, Xie X, Ren X, et al: Metabolic recoding of NSUN2-Mediated m(5)C modification promotes the progression of colorectal cancer via the NSUN2/YBX1/m(5)C-ENO1 positive feedback loop. Adv Sci (Weinh). 11:e23098402024. View Article : Google Scholar : PubMed/NCBI

143 

Liu J, Du J, Li Y, Wang F, Song D, Lin J, Li B and Li L: Catalpol induces apoptosis in breast cancer in vitro and in vivo: Involvement of mitochondria apoptosis pathway and post-translational modifications. Toxicol Appl Pharmacol. 454:1162152022. View Article : Google Scholar : PubMed/NCBI

144 

Lai FL and Gao F: Auto-Kla: a novel web server to discriminate lysine lactylation sites using automated machine learning. Brief Bioinform. 24:bbad0702023. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Yang Y, Zhang N, Wang D, Ye D, Zhang Y and Li X: Metabolic‑epigenetic coupling via lysine lactylation drives cancer stemness and multidrug resistance (Review). Int J Oncol 69: 142, 2026.
APA
Yang, Y., Zhang, N., Wang, D., Ye, D., Zhang, Y., & Li, X. (2026). Metabolic‑epigenetic coupling via lysine lactylation drives cancer stemness and multidrug resistance (Review). International Journal of Oncology, 69, 142. https://doi.org/10.3892/ijo.2026.5955
MLA
Yang, Y., Zhang, N., Wang, D., Ye, D., Zhang, Y., Li, X."Metabolic‑epigenetic coupling via lysine lactylation drives cancer stemness and multidrug resistance (Review)". International Journal of Oncology 69.6 (2026): 142.
Chicago
Yang, Y., Zhang, N., Wang, D., Ye, D., Zhang, Y., Li, X."Metabolic‑epigenetic coupling via lysine lactylation drives cancer stemness and multidrug resistance (Review)". International Journal of Oncology 69, no. 6 (2026): 142. https://doi.org/10.3892/ijo.2026.5955
Copy and paste a formatted citation
x
Spandidos Publications style
Yang Y, Zhang N, Wang D, Ye D, Zhang Y and Li X: Metabolic‑epigenetic coupling via lysine lactylation drives cancer stemness and multidrug resistance (Review). Int J Oncol 69: 142, 2026.
APA
Yang, Y., Zhang, N., Wang, D., Ye, D., Zhang, Y., & Li, X. (2026). Metabolic‑epigenetic coupling via lysine lactylation drives cancer stemness and multidrug resistance (Review). International Journal of Oncology, 69, 142. https://doi.org/10.3892/ijo.2026.5955
MLA
Yang, Y., Zhang, N., Wang, D., Ye, D., Zhang, Y., Li, X."Metabolic‑epigenetic coupling via lysine lactylation drives cancer stemness and multidrug resistance (Review)". International Journal of Oncology 69.6 (2026): 142.
Chicago
Yang, Y., Zhang, N., Wang, D., Ye, D., Zhang, Y., Li, X."Metabolic‑epigenetic coupling via lysine lactylation drives cancer stemness and multidrug resistance (Review)". International Journal of Oncology 69, no. 6 (2026): 142. https://doi.org/10.3892/ijo.2026.5955
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team